• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
News and impact
NIHR Biomedical Research Centre Leicester

NIHR Biomedical Research Centre Leicester

  • Home
  • About Us
    • Leadership Team
    • Our Impact
    • Our NIHR infrastructure
    • Governance
    • Inclusion
    • Strategies
    • Contact us
  • Our Research
    • Our Impact
    • Spotlight on our researchers
    • Cardiovascular
    • Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health
    • Environment
    • Lifestyle
    • Personalised Cancer Prevention and Treatment
    • Respiratory and Infection
  • Patients and Public
    • Get Involved
    • Upcoming Public Involvement opportunities
    • Our approach to Public Involvement
    • Join the BioResource and Be Part of Research
    • Taking part in Clinical Trials
  • Industry and Partners
    • What we offer to industry
    • Collaborate with the Leicester BRC
    • Our partnerships
      • The NIHR Diet and Activity Research Translation (DART) Collaboration
  • For Researchers
    • Training
    • The Internal Resource Hub
    • Acknowledging and communicating your research
    • Guidance on Public Involvement (PPIE) for researchers
    • Advancing inclusion: transforming research culture in Leicester and beyond
    • PPI for Statistical Methodology and Research Techniques
  • News and Impact

Researchers in Leicester launch study to untangle organ damage after COVID-19

Apr 5, 2022

A new study investigating the extent to which COVID-19 damages organs has opened in Leicester this week.

Led by the National Institute for Health Research (NIHR) Leicester Biomedical Research Centre – a partnership between Leicester’s Hospitals, the University of Leicester and Loughborough University, the COSMIC study will be using MRI scans of participants, along with health records and blood tests, to compare the organs of people who have never had COVID-19 to those who have previously been infected. The research team hope the findings will help to better understand the extent to which organ damage is caused by COVID-19 and what is caused by other underlying health conditions.

COVID-19 is largely thought of as a respiratory disease which primarily affects the lungs. During the pandemic, Urgent Public Health (UPH) studies such as C-MORE and COVID-HEART recruited over 900 people who have had COVID-19, including 115 in Leicester, to investigate the impact on other organs.  Studies like these have shown the virus can damage other organs, including the heart, brain, liver and kidneys. Researchers now want to know how COVID-19 causes this damage, with the aim to find potential treatments.

Health conditions such as chronic obstructive pulmonary disease (COPD), type 2 diabetes or heart disease are known risk factors for COVID-19. This means many people who have had COVID-19 also have one or more of these conditions. Many of these conditions can also cause organ damage so it can be difficult to tell what damage has been caused by COVID-19, and what would have been caused by these other conditions in the same timeframe. The COSMIC study team hope to begin untangling this issue.

Dr Ranjit Arnold, who is leading the COSMIC study in Leicester, said: “We know that how poorly someone becomes during and after COVID-19 infection depends on many factors, including their age, socioeconomic background, and whether they have other health conditions.

“Teasing out how much organ damage is due to the virus itself rather than these other underlying health conditions is key to improving our understanding of how COVID-19 can affect the organs. To do this we will ask a large group of people who haven’t had COVID-19 but may have similar underlying health conditions to participants we’ve recruited in trials so far to make comparisons.”

Participants on the COSMIC trial will undergo an MRI scan on their heart, lungs, liver, kidneys and brain, which will be used to compare to those who have had COVID-19.

Dr Arnold said: “MRI scans are perfect for this sort of research. Using our state-of-the-art scanner based at Glenfield Hospital we can investigate the condition of people’s organs without any sort of invasive procedure. The scanner helps us accurately assess the structure and function of the major organs. By using these scans we will be able to investigate how frequently damage occurs, and further down the line this will give us information regarding injury patterns, and whether a COVID-19 has a specific damage pattern.”

For more information about the COSMIC study email: cardiologyresearch@uhl-tr.nhs.uk or call 0116 2583385.

Category: Press ReleasesTag: coronavirus, covid, long covid, mri, News, Press Release, scanner

Sidebar

Recent News

Virtual wards could offer alternative to hospital care for heart rhythm patients

BBC help launch campaign to improve awareness of Peripheral Artery Disease

Research.com rankings place University of Leicester in UK’s top 25

Read more news stories

The NIHR Leicester BRC is part of the NIHR and hosted by the University Hospitals of Leicester NHS Trust in partnership with the University of Leicester,  Loughborough University and the University Hospitals of the Northamptonshire NHS Group.

Get in touch

NIHR Leicester Biomedical Research Centre

University Hospitals of Leicester NHS Trust
Research & Innovation
Leicester General Hospital
Gwendolen Road
Leicester, LE5 4PW

Contact us

Our Research

Spotlight on our researchers

Cardiovascular

Data Innovation for Multiple Long-Term Health Conditions and Ethnic Health

Environment

Personalised Cancer Prevention and Treatment

Lifestyle

Respiratory and Infection

About BRC

Our NIHR infrastructure

BRC clinical research during COVID-19

Our 2022 – 2028 strategy documents

Governance

Useful links

Our partnerships

Inclusion

Privacy notice

Cookie Policy

Copyright © NIHR Biomedical Research Centre: Leicester

  • LinkedIn
  • X
  • Facebook
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}